Abivax Sa earnings were -$195.0M for the trailing 12 months ending Jun 30, 2024, with N/A growth year over year. The latest ABVX earnings report on Jun 30, 2024 announced Q2 2024 earnings of N/A, down N/A from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, ABVX reported annual earnings of -$164.2M, with 154% growth. The next ABVX earnings date is Mar 31, 2025.
On ABVX's earnings call on Invalid Date, Abivax Sa (NASDAQ: ABVX) reported Q2 2024 earnings per share (EPS) of N/A, up N/A year over year. Total ABVX earnings for the quarter were N/A. In the same quarter last year, Abivax Sa's earnings per share (EPS) was N/A.
The next ABVX earnings date is Invalid Date. Add ABVX to your watchlist to be reminded of Abivax Sa's next earnings date.
What was ABVX's earnings growth in the past year?
As of Abivax Sa's earnings date in Invalid Date, Abivax Sa's earnings has grown year over year. ABVX earnings in the past year totalled -$194.97 million.
Is Abivax Sa profitable or losing money?
As of the last Abivax Sa earnings report, Abivax Sa is currently losing money. Abivax Sa's net profit (also called net income) for the twelve months ending Jun 30, 2024 was -$190.78 million, a 89.72% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.